Mielóma multiplex: nyitott vizsgálatok itt: Dánia

27 nyitott vizsgálatnak van helyszíne itt: Dánia. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
Aalborg University Hospital, Aalborg · Region Midtjylland, Herning · Næstved Hospital, Næstved · Sygehus Lillebaelt - Vejle Sygehus, Vejle
Regiszter frissítve: 2026-11-03
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Kísérleti kezelés · 3. fázis · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C · Region Sjaelland, Roskilde
Regiszter frissítve: 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Kísérleti kezelés · 3. fázis · Pfizer
Aarhus Universitetshospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C · Lillebaelt Hospital, Vejle
Regiszter frissítve: 2026-10-27
NCT07634263
Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study
Kutatás · Odense University Hospital
Copenhagen University Hospital, Rigshospitalet, Copenhagen · Odense University Hospital, Odense · Sjællands Universitets Hospital, Roskilde
Regiszter frissítve: 2026-10-23
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Kísérleti kezelés · 3. fázis · AstraZeneca
Aarhus · København Ø · Odense
Regiszter frissítve: 2026-10-21
NCT04910568
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Kísérleti kezelés · 1. fázis · Genentech, Inc.
Rigshospitalet, Copenhagen Oe
Regiszter frissítve: 2026-10-20
NCT07878208
Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies
Kutatás · Odense University Hospital
Aarhus University Hospital, Aarhus · Copenhagen University Hospital, Copenhagen · Regional Hospital Gødstrup, Gødstrup · Odense University Hospital, Odense · Zealand University Hospital, Roskilde, Roskilde · Vejle Hospital, Vejle
Regiszter frissítve: 2026-10-16
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Kísérleti kezelés · 3. fázis · CSL Behring
Rigshospitalet, Copenhagen · Zealand University Hospital, Roskilde · Department of Medicine, Vejle Hospital, Vejle
Regiszter frissítve: 2026-10-14
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Kísérleti kezelés · 3. fázis · Takeda
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Regiszter frissítve: 2026-10-13
NCT07555938
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Sjaelland, Roskilde · Lillebaelt Hospital, Vejle
Regiszter frissítve: 2026-10-13
2026-525367-40-00
A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.
Kísérleti kezelés · 3. fázis · AstraZeneca AB
Region Midtjylland, Aarhus N · Region Hovedstaden, Copenhagen Oe · Region Syddanmark, Odense C
Regiszter frissítve: 2026-10-12
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Kísérleti kezelés · 3. fázis · European Myeloma Network B.V.
Aarhus Universitetshospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Nyborg · Lillebaelt Hospital, Vejle
Regiszter frissítve: 2026-10-07
NCT07842198
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
Kísérleti kezelés · 2. fázis · Zealand University Hospital
Zealand University Hospital, Roskilde
Regiszter frissítve: 2026-09-25
2025-524014-29-00
A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma
Kísérleti kezelés · 3. fázis · AstraZeneca AB
Region Midtjylland, Aarhus N
Regiszter frissítve: 2026-09-08
NCT06285318
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Kutatás · Janssen-Cilag Ltd.
Aalborg Sygehus Syd, Aalborg · Aarhus Universitetshospital, Aarhus N · Rigshospitalet, Copenhagen · Odense University Hospital, Odense · Sygehus Lillebælt - Vejle, Vejle
Regiszter frissítve: 2026-08-28
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Kísérleti kezelés · 3. fázis · Pfizer
Aalborg University Hospital, Aalborg · Aarhus Universitetshospital, Aarhus N · Rigshospitalet, Copenhagen Oe
Regiszter frissítve: 2026-08-24
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Kísérleti kezelés · 3. fázis · AstraZeneca
Århus N
Regiszter frissítve: 2026-08-14
NCT05444348
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
Kísérleti kezelés · Christoffer Johansen
Aalborg Universitetshospital, Aalborg · Aarhus Universitetshospital, Aarhus · Sydvestjysk sygehus - Esbjerg, Esbjerg · Regionshospitalet Gødstrup, Herning · Odense Universitetshospital, Odense · Sjællands Universitetshospital_Roskilde, Roskilde · Lillebælt syge - Vejle Sygehus, Vejle
Regiszter frissítve: 2026-08-12
NCT07757412
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
Kísérleti kezelés · 2. fázis · Odense University Hospital
Region Midtjylland, Aarhus N · Odense University Hospital, Odense C
Regiszter frissítve: 2026-08-11
NCT04077307
A Study in Leukemia Patients With Karonudib
Kísérleti kezelés · 1. fázis · Thomas Helleday Foundation
Aarhus University Hospital, Aarhus · Rigshospitalet (Copenhagen University Hospital), Copenhagen
Regiszter frissítve: 2026-08-06
NCT05650632
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Kísérleti kezelés · 1. fázis · AbbVie
Odense University Hospital, Odense C · Lillebaelt Hospital, Vejle
Regiszter frissítve: 2026-07-13
NCT07558057
Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study
Kutatás · Aarhus University Hospital
Aarhus University Hospital, Aarhus
Regiszter frissítve: 2026-04-30
NCT06932562
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Kísérleti kezelés · 3. fázis · European Myeloma Network B.V.
Region Midtjylland, Aarhus N · Region Sjaelland, Roskilde
Regiszter frissítve: 2026-03-25
NCT07474961
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
Kísérleti kezelés · 4. fázis · Anne Louise Tølbøll Sørensen
Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus · Copenhagen University Hospital, Rigshospitalet, Copenhagen · Odense University Hospital, Odense · Roskilde University Hospital, Roskilde
Regiszter frissítve: 2026-03-16
NCT06015542
Self-administration of Subcutaneous Elranatamab in the Patients' Homes.
Kísérleti kezelés · 2. fázis · Thomas Lund
Odense University Hospital, Odense C · Sygehus Lillebaelt - Vejle Sygehus, Vejle
Regiszter frissítve: 2026-02-10

Minden vizsgálat (Mielóma multiplex) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek